HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 1,6- dideoxyglucopyranose

inhibits sodium-dependent glucose cotransporter 2 (SGLT2); structure in first source

Also Known As:

6-deoxydapagliflozin

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Benzhydryl Compounds
        1-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1,6-dideoxyglucopyranose: 1
Carbohydrates: 22023
- Deoxy Sugars: 6
  - Deoxyglucose: 2901
    - 1-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1,6-dideoxyglucopyranose: 1

Experts

1.	Liu, Bingni: 1 article (05/2014)
2.	Shi, Yongheng: 1 article (05/2014)
3.	Tang, Lida: 1 article (05/2014)
4.	Wang, Jianwu: 1 article (05/2014)
5.	Wang, Yuli: 1 article (05/2014)
6.	Wei, Qunchao: 1 article (05/2014)
7.	Xu, Huaqiang: 1 article (05/2014)
8.	Xu, Weiren: 1 article (05/2014)
9.	Zhang, Lingyu: 1 article (05/2014)
10.	Zhao, Guilong: 1 article (05/2014)

Related Diseases

1.	Type 2 Diabetes Mellitus (MODY) 05/01/2014 - "Discovery of 6-deoxydapagliflozin as a highly potent sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes."

Related Drugs and Biologics

1.	Sodium
2.	Glucose (Dextrose)
3.	Sodium-Glucose Transporter 2 Inhibitors